|
| DNA damage repair defects as a new class of endocrine treatment resistance driver |
|
https://doi.org/10.18632/oncotarget.26363
Meenakshi Anurag, Matthew J. Ellis, and Svasti Haricharan
|
| 36252-36253 |
|
| Oncolytic virotherapy – in vivo veritas |
|
https://doi.org/10.18632/oncotarget.26364
Iris Kemler, Claudia Neuhauser, and David Dingli
|
| 36254-36255 |
|
| Calretinin promotes invasiveness and EMT in malignant mesothelioma cells involving the activation of the FAK signaling pathway |
|
https://doi.org/10.18632/oncotarget.26332
Janine Wörthmüller, Walter Blum, Laszlo Pecze, Valérie Salicio, and Beat Schwaller
|
| 36256-36272 |
|
| The estrogen receptor variants β2 and β5 induce stem cell characteristics and chemotherapy resistance in prostate cancer through activation of hypoxic signaling |
|
https://doi.org/10.18632/oncotarget.26345
Michelle Faria, Peter Shepherd, Yinghong Pan, Sujash S. Chatterjee, Nora Navone, Jan-Ã…ke Gustafsson, and Anders Strom
|
| 36273-36288 |
|
| Cytotoxic phenanthroline derivatives alter metallostasis and redox homeostasis in neuroblastoma cells |
|
https://doi.org/10.18632/oncotarget.26346
Irina Naletova, Cristina Satriano, Alessandra Curci, Nicola Margiotta, Giovanni Natile, Giuseppe Arena, Diego La Mendola, Vincenzo Giuseppe Nicoletti, and Enrico Rizzarelli
|
| 36289-36316 |
|
| Prostaglandin E2 produced by myeloidderived suppressive cells induces cancer stem cells in uterine cervical cancer |
|
https://doi.org/10.18632/oncotarget.26347
Hiromasa Kuroda, Seiji Mabuchi, Eriko Yokoi, Naoko Komura, Katsumi Kozasa, Yuri Matsumoto, Mahiru Kawano, Ryoko Takahashi, Tomoyuki Sasano, Kotaro Shimura, Michiko Kodama, Kae Hashimoto, Kenjiro Sawada, Eiichi Morii, and Tadashi Kimura
|
| 36317-36330 |
|
| Antitumor properties of Salvianolic acid B against triplenegative and hormone receptorpositive breast cancer cells via ceramidemediated apoptosis |
|
https://doi.org/10.18632/oncotarget.26348
Wei Sha, Yanfei Zhou, Zhi-Qiang Ling, Guiqin Xie, Xiaowu Pang, Paul Wang, and Xinbin Gu
|
| 36331-36343 |
|
| Targeted nextgeneration sequencing reveals recurrenceassociated genomic alterations in earlystage nonsmall cell lung cancer |
|
https://doi.org/10.18632/oncotarget.26349
William C.S. Cho, Kien Thiam Tan, Victor W.S. Ma, Jacky Y.C. Li, Roger K.C. Ngan, Wah Cheuk, Timothy T.C. Yip, Yi-Ting Yang, and Shu-Jen Chen
|
| 36344-36357 |
|
| The phosphorylation status of PIP5K1C at serine 448 can be predictive for invasive ductal carcinoma of the breast |
|
https://doi.org/10.18632/oncotarget.26357
Nisha Durand, Sahra Borges, Tavia Hall, Ligia Bastea, Heike Döppler, Brandy H. Edenfield, Aubrey E. Thompson, Xochiquetzal Geiger, and Peter Storz
|
| 36358-36370 |
|
| Diagnostic performance of GdEOBDTPAenhanced MRI for evaluation of liver dysfunction: a multivariable analysis of 3T MRI sequences |
|
https://doi.org/10.18632/oncotarget.26368
Niklas Verloh, Kirsten Utpatel, Florian Zeman, Claudia Fellner, Hans J. Schlitt, Martina Müller, Christian Stroszczynski, Matthias Evert, Philipp Wiggermann, and Michael Haimerl
|
| 36371-36378 |
|
| Synthetic lethal combinations of lowtoxicity drugs for breast cancer identified in silico by genetic screens in yeast |
|
https://doi.org/10.18632/oncotarget.26372
Maximilian Marhold, Erwin Tomasich, Michael Schwarz, Simon Udovica, Andreas Heinzel, Paul Mayer, Peter Horak, Paul Perco, and Michael Krainer
|
| 36379-36391 |
|
| Water transport proteins–aquaporins AQPs in cancer biology |
|
https://doi.org/10.18632/oncotarget.26351
Salah Dajani, Anand Saripalli, and Neelam Sharma-Walia
|
| 36392-36405 |
|
| Correction: Prognostic and clinicopathological value of p53 expression in renal cell carcinoma: a metaanalysis |
|
https://doi.org/10.18632/oncotarget.26394
Zhun Wang, Shuanghe Peng, Ning Jiang, Aixiang Wang, Shuguang Liu, Hui Xie, Linpei Guo, Qiliang Cai, and Yuanjie Niu
|
| 36406-36406 |
